As the landscape of cardiac care evolves, physicians are increasingly demanding a higher fidelity of information during diagnostic and therapeutic procedures. The era of "add-on" sensors—peripheral attachments that provided limited, siloed data—is rapidly drawing to a close. In its place, the industry is shifting toward embedded, multi-parameter platforms designed to support real-time clinical decision-making in the electrophysiology (EP) lab, while simultaneously providing long-term longitudinal insights for chronic conditions such as heart failure.
This transition represents a significant leap forward in patient care, but it also creates a formidable engineering paradox: how can manufacturers pack more sensing capabilities into devices without increasing their physical footprint, sacrificing mechanical flexibility, or compromising long-term reliability? To explore this shifting technological landscape and its implications for Original Equipment Manufacturers (OEMs), Medical Device Network sat down with Cacie McDorman, Ph.D., Global Product Manager for Wire Technologies at Alleima’s medical unit.
The Core Signals: Defining the Diagnostic Foundation
For decades, the bedrock of cardiac rhythm management has been surface ECG and intracardiac electrograms (EGM). These remain the gold standard for rhythm diagnosis, mapping, pacing response, and determining ablation endpoints. However, the modern EP lab is moving beyond simple electrical tracing.
"The core signals are still surface ECG and intracardiac electrograms because they are the foundation for rhythm diagnosis," explains Dr. McDorman. "However, pressure, impedance, temperature, and imaging add crucial context. Pressure helps us understand hemodynamics; impedance indicates tissue or fluid changes; temperature supports procedural safety; and ultrasound or intracardiac echo provides the necessary anatomical orientation."
The current trend is shifting toward "practical insight at the treatment site." Engineers are no longer looking for one "hero" signal; they are looking for a symphony of data points. This includes tracking tissue contact, proximity, local conductivity, distributed temperature, and electro-mechanical motion. Furthermore, as Pulsed Field Ablation (PFA) enters the mainstream, the need to monitor local field exposure has become a priority to ensure both safety and efficacy.
Multimodal Sensing: The Art of Actionable Insight
When discussing multimodal sensing—the integration of multiple sensor types into a single catheter—the primary goal is to answer specific, actionable clinical questions. The most successful combinations are those that connect the electrical response of the heart with the physical reality of the catheter’s position.
"For EP and ablation, the combination of electrograms with contact/proximity, local impedance, and mapping/imaging is exceptionally powerful," says Dr. McDorman. "It creates a bridge between the electrical behavior of the myocardium and the physical catheter-tissue interface."
When an EP specialist uses these combined signals, they are effectively confirming a "chain of causality":
- Electrograms show what the myocardium is doing.
- Contact/Proximity sensors confirm that energy is effectively coupling into the target tissue.
- Impedance provides data on the quality of the tissue-device interface.
- Mapping/Imaging confirms that the correct anatomical structure has been treated.
From a wire-technology perspective, this is a significant challenge. Multimodal sensing necessitates a higher density of conductors, more complex termination points, and intricate insulation interfaces, all packed within a catheter body that must remain small enough to navigate the delicate anatomy of the human heart.
Engineering Hurdles: The "Space-Reliability" Paradox
The barriers to integrating these advanced sensors are primarily architectural. Every new sensor added to a lead or catheter competes for limited real estate. Engineers must balance insulation thickness, termination surface area, and the mechanical flexibility required to traverse the vascular system.
"The biggest barriers are space, reliability, and system integration," Dr. McDorman notes. "Materials must function in harmony with electrodes, coatings, and polymers, while surviving sterilization, blood contact, and millions of cycles of cardiac fatigue."
Furthermore, Electromagnetic Interference (EMI) presents a significant hurdle. In high-energy environments—particularly during PFA—low-level sensing signals are often in close proximity to high-voltage energy lines. This necessitates advanced shielding, filtering, and isolation techniques. If a system cannot maintain signal integrity while high-voltage pulses are being delivered, the sensor data becomes corrupted, potentially leading to incorrect clinical decisions.
Clinical Implications: Latency and Data Utility
The value of sensor data is intrinsically linked to the speed at which it can be delivered to the physician. Not all cardiac data requires the same latency profile.
- Real-time Decision Support: For EGM and ECG signals, millisecond-level timing is non-negotiable. These signals guide immediate, high-stakes decisions regarding rhythm management and ablation.
- Procedural Monitoring: Contact, proximity, and force data must update rapidly enough to reflect the dynamic nature of catheter movement and tissue engagement.
- Safety Monitoring: Temperature monitoring can operate on a sub-second to seconds-level basis.
- Hemodynamic Analysis: Pressure and flow sensors require high waveform fidelity to support acute hemodynamic decision-making.
"For heart failure monitoring," Dr. McDorman adds, "the focus shifts from low-latency responsiveness to trend accuracy, drift stability, and long-term consistency. In that context, we are looking at data over weeks and months rather than milliseconds."
The ROI of Advanced Sensing
In an era of cost-conscious healthcare, every new feature must be justified by its return on investment (ROI). EP labs are measuring the value of advanced sensing through several key performance indicators:
- Procedural Efficiency: Shortening procedure times and improving throughput.
- Patient Safety: Reducing the need for repeat procedures and minimizing complication risks.
- Clinical Standardization: Reducing operator variability and ensuring that clinical outcomes remain consistent regardless of the physician’s experience level.
"The real test is whether the sensor changes the workflow in a useful way," says Dr. McDorman. "If it only creates more data without making a decision easier, it will be hard to justify the cost. But if it reduces the need for fluoroscopy, decreases anesthesia time, or ensures first-pass success, the value proposition is clear."
PFA and the Future of Lesion Success
Pulsed Field Ablation (PFA) has introduced a new paradigm in cardiac electrophysiology. Because PFA uses high-voltage, microsecond-scale pulses, the sensor requirements are far more stringent than those of traditional radiofrequency (RF) ablation.
"PFA changes the sensor architecture significantly," Dr. McDorman explains. "Low-level signals now reside in the same ecosystem as high-voltage bursts. This demands superior dielectric strength, rigorous leakage control, and sophisticated grounding and shielding."
The industry is moving toward "lesion-quality indices," but as Dr. McDorman emphasizes, there is no "silver bullet" measurement for PFA success. Instead, the industry is coalescing around a comprehensive approach: combining catheter-tissue contact, delivered field/dose, electrogram response, local impedance, and post-ablation mapping. The safety of the patient depends on the integrity of the wire and coating systems—ensuring that insulation is uniform, pinhole-free, and capable of resisting the electrical stress of PFA.
Design for Manufacturability (DFM)
Perhaps the most critical lesson in the evolution of medical sensing is that design cannot be separated from production. "We need to think about manufacturability from the concept stage," says Dr. McDorman. "A sensing feature that works in a prototype but cannot survive the rigors of mass production, sterilization, or shelf-life is not a viable product."
This is where the partnership between the OEM and the materials supplier becomes strategic. Alleima, leveraging over 160 years of metallurgical expertise, acts as a critical partner in this process. By combining advanced alloys with precision-engineered wire, they help OEMs move beyond "commodity specifications" to create custom solutions that are robust enough for the modern EP lab.
As the industry pushes toward increasingly complex diagnostic tools, the reliance on high-performance materials will only intensify. The future of cardiac care lies in the ability to seamlessly integrate these sophisticated, sensing-enabled instruments into the daily workflow of the physician—making the complex, simple; and the invisible, clear.
For more information on the next generation of sensor-integrated technologies, visit www.alleima.com/sensing.
About the Author
